SGLT2 inhibition in cardiology: what a cardiologist needs to know.

28 August 2017 (15:50 - 15:55)
Organised by:
Congress Presentation Part of: Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure (EBAC Accredited) Diabetes, dysglycaemia and metabolic syndrome ESC Premium Access ESC Congress 2017

About the speaker

Photo

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

2 More presentations in this session

Presentation thumbnail
Professor S. Anker (Berlin, DE) Professor J. Deanfield (London, GB) Professor N. Sattar (Glasgow, GB) Doctor D. Fitchett (Toronto, CA)

The Event

Event poster

ESC Congress 2017

28 August 2017 15:50 CET

ESC 365 is supported by

ESC 365 is supported by